CryoPort, Inc. to Ship Clinical Specimens for Quest Diagnostics Inc.

LAKE FOREST, CA--(Marketwire - October 22, 2008) - CryoPort, Inc. (OTCBB: CYRX) today announced that it has reached an agreement to begin shipping frozen specimens for Quest Diagnostics. This is the initial phase of a multi-stage program. This first phase involves shipments made for Quest Diagnostics Clinical Trials from their laboratory in Gurgaon, India to multiple locations in the U.S. The shipments will be sent using the CryoPort Express™ One-Way Shipper and their transportation will be managed by Federal Express.